Mutations in RNA splicing factors (SF3B1, SRSF2, U2AF1, U2AF2 and ZRSR2) represent the most common class of genetic alterations in MDS, as they are present in 50–60% of MDS patients. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.